Noveltreat 0.25 mg ( Semaglutide ) Exporter from India to Washington, USA, Zimbabwe & New Zealand
City Drug Exporters specializes in exporting Noveltreat 0.25 mg ( Semaglutide ) from India to international markets including Washington, USA, Zimbabwe, and New Zealand.
We provide dependable supply solutions for pharmaceutical wholesalers, distributors, pharmacies, and healthcare procurement companies. Noveltreat 0.25 mg ( Semaglutide ) Know its uses, benefits , Side effects, and storage details.
Noveltreat 0.25 mg ( Semaglutide ) , a GLP-1 receptor agonist prescribed for chronic weight management and blood sugar control in type 2 diabetes, used alongside diet and exercise. Common side effects include nausea, vomiting, diarrhea, and fatigue. Store unexpired pens in a refrigerator (2°C–8°C); keep active pens at room temperature or refrigerated.
Uses :
Weight management: Helps with long-term weight reduction in adults.
Blood sugar control: Assists in managing type 2 diabetes mellitus.
Metabolic health: Improves metabolic markers when paired with a calorie-controlled diet and exercise.
Side Effects
Common: Nausea, vomiting, diarrhea, constipation, and stomach pain.
Other: Reduced appetite, headache, tiredness, and dizziness.
Serious: Severe abdominal pain (sign of pancreatitis), gallbladder problems, or allergic reactions.
Storage :
Unused pens: Keep in the refrigerator between 2°C and 8°C.
Do not freeze.In-use pens: Store below 30°C at room temperature or in a refrigerator for up to a specific number of weeks as directed on the product label.
Protection: Keep the pen cap on to protect it from light when not in use.
Precautions :
Thyroid cancer risk: Do not use if you or your family have a history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Pregnancy & breastfeeding: Avoid use during pregnancy; stop usage at least two months before a planned pregnancy.
Pancreatitis history: Inform your doctor if you have had inflammation of the pancreas.
Low blood sugar: Watch for hypoglycemia if combined with insulin or sulfonylureas.
City Drug House Exporters provides:
Bulk supply for hospitals & distributors
Export to USA. Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics
Contact for More Information :
📞 Contact City drug House Exporters from India
🌐 Websites: https://www.citydrugexporters.com
📧 Email: citydrug123@gmail.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 7666132978
City Drug Exporters specializes in exporting Noveltreat 0.25 mg ( Semaglutide ) from India to international markets including Washington, USA, Zimbabwe, and New Zealand.
We provide dependable supply solutions for pharmaceutical wholesalers, distributors, pharmacies, and healthcare procurement companies. Noveltreat 0.25 mg ( Semaglutide ) Know its uses, benefits , Side effects, and storage details.
Noveltreat 0.25 mg ( Semaglutide ) , a GLP-1 receptor agonist prescribed for chronic weight management and blood sugar control in type 2 diabetes, used alongside diet and exercise. Common side effects include nausea, vomiting, diarrhea, and fatigue. Store unexpired pens in a refrigerator (2°C–8°C); keep active pens at room temperature or refrigerated.
Uses :
Weight management: Helps with long-term weight reduction in adults.
Blood sugar control: Assists in managing type 2 diabetes mellitus.
Metabolic health: Improves metabolic markers when paired with a calorie-controlled diet and exercise.
Side Effects
Common: Nausea, vomiting, diarrhea, constipation, and stomach pain.
Other: Reduced appetite, headache, tiredness, and dizziness.
Serious: Severe abdominal pain (sign of pancreatitis), gallbladder problems, or allergic reactions.
Storage :
Unused pens: Keep in the refrigerator between 2°C and 8°C.
Do not freeze.In-use pens: Store below 30°C at room temperature or in a refrigerator for up to a specific number of weeks as directed on the product label.
Protection: Keep the pen cap on to protect it from light when not in use.
Precautions :
Thyroid cancer risk: Do not use if you or your family have a history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Pregnancy & breastfeeding: Avoid use during pregnancy; stop usage at least two months before a planned pregnancy.
Pancreatitis history: Inform your doctor if you have had inflammation of the pancreas.
Low blood sugar: Watch for hypoglycemia if combined with insulin or sulfonylureas.
City Drug House Exporters provides:
Bulk supply for hospitals & distributors
Export to USA. Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics
Contact for More Information :
📞 Contact City drug House Exporters from India
🌐 Websites: https://www.citydrugexporters.com
📧 Email: citydrug123@gmail.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 7666132978
Keywords
